Activation of lipoprotein lipase increases serum high density lipoprotein 2 cholesterol and enlarges high density lipoprotein 2 particles in rats

European Journal of Pharmacology

Volumn 668, Issue 1-2, 2011, Pages 337-339

  Kusunoki, Masataka ^a   Tsutsumi, Kazuhiko ^b   Sato, Daisuke ^c   Nakamura, Aki ^d   Habu, Satoshi ^a   Mori, Yuichi ^e   Morishita, Munehiko ^a   Yonemoto, Takayuki ^a   Miyata, Tetsuro ^f   Nakaya, Yutaka ^d   Nakamura, Takao ^c  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

^e Chukyo Women's University   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

HDL particle size; HDL cholesterol; Lipoprotein lipase activator

Indexed keywords

HIGH DENSITY LIPOPROTEIN 2; HIGH DENSITY LIPOPROTEIN 2 CHOLESTEROL; HIGH DENSITY LIPOPROTEIN 3; HIGH DENSITY LIPOPROTEIN 3 CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IBROLIPIM; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BENZAMIDES; CHOLESTEROL, HDL; ENZYME ACTIVATION; LIPOPROTEIN LIPASE; LIPOPROTEINS, HDL2; MALE; ORGANOPHOSPHORUS COMPOUNDS; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 80052055917     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.06.040     Document Type: Article

References (24)

1. M.C. Bakogianni, C.A. Kalofoutis, K.I. Skenderi, and A.T. Kalofoutis Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease J. Diab. Complications 15 2001 265 269 (Pubitemid 32750615)
2. M.C. Carr, and J.D. Brunzell Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk J. Clin. Endocrinol. Metab. 89 2004 2601 2607 (Pubitemid 38766338)
3. M.C. Cheung, B.G. Brown, A.C. Wolf, and J.J. Albers Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease J. Lipid Res. 32 1991 383 394
4. K.H. Cho Biomedical implications of high-density lipoprotein: its composition, structure, functions, and clinical applications BMB Rep. 42 2009 393 400
5. P.H. Groot, L.M. Scheek, and H. Jansen Liver lipase and high-density lipoprotein. Lipoprotein changes after incubation of human serum with rat liver lipase Biochim. Biophys. Acta 751 1983 393 400 (Pubitemid 13095028)
6. Y.C. Ha, and P.J. Barter Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species Comp. Biochem. Physiol. 71 1982 265 269
7. I. Hara, K. Shiraishi, and M. Okazaki High-performance liquid chromatography of human serum lipoproteins J. Chromatogr. 239 1982 549 557
8. D.R. Jacobs Jr., I.L. Mebane, S.I. Bangdiwala, M.H. Criqui, and H.A. Tyroler High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence study Am. J. Epidemiol. 131 1990 32 47 (Pubitemid 20014697)
9. J. Koizumi, H. Mabuchi, A. Yoshimura, I. Michishita, M. Takeda, H. Itoh, Y. Sakai, T. Sakai, K. Ueda, and R. Takeda Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia Atherosclerosis 58 1985 175 186 (Pubitemid 16173307)
10. M. Kusunoki, K. Tsutsumi, T. Hara, H. Ogawa, T. Nakamura, T. Miyata, F. Sakakibara, Y. Fukuzawa, T. Suga, S. Kakumu, and Y. Nakaya A lipoprotein lipase activator, NO-1886 prevents impaired endothelium-dependent relaxation of aorta caused by exercise in aged rats Exp. Gerontol. 37 2002 891 896 (Pubitemid 34665479)
11. T. Kuusi, C. Ehnholm, J. Viikari, R. Härkönen, E. Vartiainen, P. Puska, and M.R. Taskinen Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo- and hyperalphalipoproteinemia J. Lipid Res. 30 1989 1117 1126 (Pubitemid 19213252)
12. M. Laakso, T. Rönnemaa, K. Pyörälä, V. Kallio, P. Puukka, and I. Penttilä Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland Diab. Care 11 1988 449 463
13. J. Morgan, C. Carey, A. Lincoff, and D. Capuzzi High-density lipoprotein subfractions and risk of coronary artery disease Curr. Atheroscler. Rep. 6 2004 359 365 (Pubitemid 39359478)
14. T. Murase, and H. Uchimura A selective decline of post-heparin plasma hepatic triglyceride lipase in hypothyroid rats Metabolism 29 1980 797 801 (Pubitemid 10035093)
15. K. Nagao Simultaneous determination of hypoxanthine and xanthine in plasma and urine by high-performance liquid chromatography with column-switching system Jpn. J. Clin. Chem. 23 1994 182 187 (Pubitemid 24268265)
16. J.R. Patsch, A.M. Gotto Jr., T. Olivercrona, and S. Eisenberg Formation of high density lipoprotein2-like during lipolysis pf very low density lipoproteins in vitro Proc. Natl Acad. Sci. USA 75 1978 4519 4523 (Pubitemid 9028388)
17. A.R. Tall, and D.M. Small Plasma high-density lipoproteins N. Engl. J. Med. 299 1978 1232 1236
18. A.R. Tall Plasma high density lipoproteins. Metabolism and relationship to atherogenesis J. Clin. Invest. 86 1990 379 384 (Pubitemid 20271868)
19. A.R. Tall Plasma cholesteryl ester transfer protein J. Lipid Res. 34 1993 1255 1274 (Pubitemid 23230305)
20. 3 levels by lipoprotein lipase Clin. Chim. Acta 112 1981 325 332 (Pubitemid 11111605)
21. K. Tsutsumi, Y. Inoue, A. Shima, K. Iwasaki, M. Kawamura, and T. Murase The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis J. Clin. Investig. 92 1993 411 417 (Pubitemid 23209023)
22. K. Tsutsumi, Y. Inoue, A. Shima, and T. Murase Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the novel compound NO-1886, a lipoprotein lipase-promoting agents, in STZ-induced diabetic rats Diabetes 44 1995 414 417
23. K. Tsutsumi, Y. Inoue, A. Hagi, and T. Murase The novel compound NO-1886 elevates plasma high-density lipoprotein cholesterol levels in hamsters and rabbits by increasing lipoprotein lipase without any effect on cholesteryl ester transfer protein activity Metabolism 46 1997 257 260 (Pubitemid 27106781)
24. S. Yamashita, Y. Matsuzawa, M. Okazaki, H. Kako, T. Yasugi, H. Akioka, K. Hirano, and S. Tarui Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity Atherosclerosis 70 1988 7 12 (Pubitemid 18091697)